Skip to Content
Merck
CN
  • Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells.

Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells.

Life Sciences (2001)
Singh NP